Acute Intermittent Porphyria Management

Introduction to AIP Treatment

The American College of Gastroenterology recommends intravenous hemin as the cornerstone of treatment for acute attacks requiring hospitalization, with a dosing protocol of 3-4 mg/kg body weight once daily for 4 consecutive days, administered preferably through a high-flow central vein 1
The American Association for the Study of Liver Diseases suggests that pain management is crucial during acute attacks, and aggressive analgesic therapy, including opioids, is often necessary despite addiction risk 1
The European Association for the Study of the Liver recommends that patients with acute intermittent porphyria should be counseled to avoid precipitating factors, including medications that induce cytochrome P450, alcohol, tobacco, caloric deprivation, and hormonal fluctuations 2

The American College of Gastroenterology recommends that intravenous hemin should be initiated emergently once diagnosis is suspected, and treatment should include aggressive pain control and management of electrolyte abnormalities, with hyponatremia occurring in 25-60% of acute attacks and requiring slow correction 1, 2
The American Association for the Study of Liver Diseases suggests that seizure management is critical, and safe anticonvulsants such as magnesium sulfate, benzodiazepines, or levetiracetam should be used, while avoiding barbiturates, hydantoins, carbamazepine, and valproic acid 2

The American College of Gastroenterology recommends that prophylactic therapy should be initiated for young women with 4 or more attacks per year, with options including givosiran, an RNA interference therapy that targets ALAS1, and prophylactic hemin infusions 2, 1
The European Association for the Study of the Liver suggests that hormonal management is crucial for young women with menstrual-associated attacks, and GnRH agonists should be initiated during days 1-3 of the menstrual cycle to suppress ovulation, with low-dose estradiol patch added after 3 months to minimize menopausal symptoms and bone loss 3

The American Association for the Study of Liver Diseases recommends that young women with AIP require structured surveillance for complications, including annual assessments of renal function, blood pressure monitoring, complete blood count and ferritin, and liver function tests 4
The American College of Gastroenterology suggests that hepatocellular carcinoma screening should begin at age 50 with liver imaging every 6-12 months for patients with recurrent or past attacks, and alpha-fetoprotein should be measured alongside imaging 3

The American Association for the Study of Liver Diseases recommends that patients with recurrent attacks require psychiatric evaluation and pain specialist referral, with significantly decreased quality of life due to chronic pain, fatigue, anxiety, and depression 3, 5
The European Association for the Study of the Liver suggests that long-term benefit can be achieved from treatment of co-existent anxiety or depression, and high risk for opioid dependence requires careful management 3

The American College of Gastroenterology recommends that liver transplantation should be reserved for patients with severe, disabling, intractable attacks refractory to hemin and givosiran therapy, with orthotopic liver transplantation being curative but carrying significant morbidity and mortality 5, 2
The American Association for the Study of Liver Diseases suggests that combined liver-kidney transplantation benefits patients with both recurrent attacks and end-stage renal disease, and patients with advanced neuropathy are poor transplant candidates 5